Effect of head and neck cancer supernatant and CpG-oligonucleotides on migration and IFN-α production of plasmacytoid dendritic cells

Anticancer Research

Volumn 29, Issue 8, 2009, Pages 3019-3025

  Thiel, Annette ^a   Pries, Ralph ^a   Jeske, Sabrina ^a   Trenkle, Thomas ^a   Wollenberg, Barbara ^a,b  

^a University of Schleswig Holstein Campus Lübeck ^*  (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

CpG; HNSCC; IFN ; Migration; Plasmacytoid dendritic cell

Indexed keywords

ALPHA INTERFERON; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CPG OLIGODEOXYNUCLEOTIDE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SUPERNATANT;

CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CHEMOKINE CCL4; CHEMOKINE CXCL12; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; INTERFERON-ALPHA; OLIGODEOXYRIBONUCLEOTIDES; RECEPTORS, CCR5; RECEPTORS, CXCR4; TUMOR CELLS, CULTURED;

EID: 68549085207     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Sozzani S: Dendritic cell trafficking: More than just chemokines. Cytokine Growth Factor Rev 6: 581-592, 2005.
2. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Ait-Yahia S, Briere F, Zlotnik A, Lebecque S and Caux C: Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188: 373-386, 1998. (Pubitemid 28357765)
3. D'Amico G, Bianchi G, Bernasconi S, Bersani L, Piemonti L, Sozzani S, Mantovani A and Allavena P: Adhesion, transendothelial migration, and reverse transmigration of in vitro cultured dendritic cells. Blood 92: 207-214, 1998. (Pubitemid 28303194)
4. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S and Lanzavecchia A: Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28: 2760-2769, 1998. (Pubitemid 28425234)
5. Sozzani S, Sallusto F, Luini W, Zhou D, Piemonti L, Allavena P, Van Damme J, Valitutti S, Lanzavecchia A and Mantovani A: Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J Immunol 155: 3292-3295, 1995.
6. Sozzani S, Luini W, Borsatti A, Polentarutti N, Zhou D, Piemonti L, D'Amico G, Power CA, Wells TN, Gobbi M, Allavena P and Mantovani A: Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 159: 1993-2000, 1997. (Pubitemid 127484190)
7. McKenna K, Beignon AS and Bhardwaj N: Plasmacytoid dendritic cells: linking innate and adaptive immunity. J Virol 79: 17-27, 2005. (Pubitemid 39648359)
8. Vanbervliet B, Bendriss-Vermare N, Massacrier C, Homey B, de Bouteiller O, Briere F, Trinchieri G and Caux C: The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J Exp Med 198: 823-830, 2003. (Pubitemid 37087780)
9. Facchetti F, de Wolf-Peeters C, van den Oord JJ, de Vos R and Desmet VJ: Plasmacytoid monocytes (so-called plasmacytoid T-cells) in Kikuchi's lymphadenitis. An immunohistologic study. Am J Clin Pathol 92: 42-50, 1989. (Pubitemid 19172921)
10. Colonna M, Krug A and Cella M: Interferon-producing cells: on the front line in immune responses against pathogens. Curr Opin Immunol 14: 373-379, 2002. (Pubitemid 34327981)
11. Muller-Hermelink HK, Stein H, Steinmann G and Lennert K: Malignant lymphoma of plasmacytoid T-cells. Morphologic and immunologic studies characterizing a special type of T-cell. Am J Surg Pathol 7: 849-862, 1983. (Pubitemid 14222471)
12. Vollenweider R and Lennert K: Plasmacytoid T-cell clusters in non-specific lymphadenitis. Virchows Arch B Cell Pathol Incl Mol Pathol 44: 1-14, 1983.
13. Meyers JH, Justement JS, Hallahan CW, Blair ET, Sun YA, O'Shea MA, Roby G, Kottilil S, Moir S, Kovacs CM, Chun TW and Fauci AS: Impact of HIV on Cell Survival and Antiviral Activity of Plasmacytoid Dendritic Cells. PLoS ONE 2: e458, 2007.
14. Rothenfusser S, Tuma E, Endres S and Hartmann G: Plasmacytoid dendritic cells: the key to CpG. Hum Immunol 63: 1111-1119, 2002. (Pubitemid 36025985)
15. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9: 271-296, 1991.
16. Cella M, Sallusto F and Lanzavecchia A: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9: 10-16, 1997. (Pubitemid 27095893)
17. Hart DN: Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90: 3245-3287, 1997.
18. Yoneyama H, Matsuno K and Matsushimaa K: Migration of dendritic cells. Int J Hematol 81: 204-207, 2005.
19. Krug A, Uppalur, R, Facchetti F, Dorner BG, Sheehan KC, Schreiber RD, Cella M and Colonna M: IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J Immunol 169: 6079-6083, 2002. (Pubitemid 36903450)
20. Yoneyama H, Matsuno K, Zhang Y, Nishiwaki T, Kitabatake M, Ueha S, Narumi S, Morikawa S, Ezaki T, Lu B, Gerard C, Ishikawa S and Matsushima K: Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol 16: 915-928, 2004. (Pubitemid 38967174)
21. Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, Paniyadi J, Matloubian M and Cyster JG: Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 169: 424-433, 2002. (Pubitemid 34686164)
22. de la Rosa G, Longo N, Rodriguez-Fernandez JL, Puig-Kroger A, Pineda A, Corbi AL and Sanchez-Mateos P: Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration. J Leukoc Biol 73: 639-649, 2003. (Pubitemid 38040477)
23. Bendriss-Vermare N, Chaperot L, Peoc'h M, Vanbervliet B, Jacob MC, Briere F, Bensa JC, Caux C and Plumas J: In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response. Leukemia 18: 1491-1498, 2004.
24. Penna G, Vulcano M, Sozzani S and Adorini L: Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum Immunol 63: 1164-1171, 2002. (Pubitemid 36025991)
25. Hartmann E, Wollenberg B, Rothenfusser S, Wagner M, Wellisch D, Mack B, Giese T, Gires O, Endres S and Hartmann G: Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res 63: 6478-6487, 2003. (Pubitemid 37255200)
26. Pries R and Wollenberg B: Cytokines in head and neck cancer. Cytokine Growth Factor Rev 17: 141-146, 2006.
27. Chin D, Boyle GM, Theile DR, Parsons PG and Coman WB: Molecular introduction to head and neck cancer (HNSCC) carcinogenesis. Br J Plast Surg 57: 595-602, 2004. (Pubitemid 40348040)
28. Douglas WG, Tracy E, Tan D, Yu J, Hicks WL Jr, Rigual NR, Loree TR, Wang Y and Baumann H: Development of head and neck squamous cell carcinoma is associated with altered cytokine responsiveness. Mol Cancer Res 2: 585-593, 2004. (Pubitemid 39403387)
29. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K and Akira S: A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745, 2000. (Pubitemid 32015992)
30. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA and Klinman DM: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546-549, 1995.
31. Bauer S and Wagner H: Bacterial CpG-DNA licenses TLR9. Curr Top Microbiol Immunol 270: 145-154, 2002.
32. Hartmann G, Krug A, Eigler A, Moeller J, Murphy J, Albrecht R and Endres S: Specific suppression of human tumor necrosis factor-alpha synthesis by antisense oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev 6: 291-299, 1996. (Pubitemid 27045906)
33. Kawamata H, Nakashiro K, Uchida D, Harada K, Yoshida H and Sato M: Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines. Int J Cancer 70: 120-127, 1997. (Pubitemid 27059715)
34. Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas ZK, Endres S, Krieg AM and Hartmann G: Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol 31: 2154-2163, 2001. (Pubitemid 32640732)
35. Mann EA Spiro JD, Chen LL and Kreutzer DL: Cytokine expression by head and neck squamous cell carcinomas. Am J Surg 164: 567-573, 1992.
36. Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, McCullagh L, Mousa S, Quezado M, Herscher LL and Van Waes C: Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 5: 1369-1379, 1999. (Pubitemid 29282941)
37. Woods KV, El-Naggar A, Clayman GL and Grimm EA: Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res 58: 3132-3141, 1998. (Pubitemid 28335097)
38. Eisma RJ, Spiro JD and Kreutzer DL: Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. Am J Surg 174: 513-517, 1997. (Pubitemid 27486016)
39. Pries R, Thiel A, Brocks C and Wollenberg B: Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma. In Vivo 20: 45-48, 2006. (Pubitemid 43103715)
40. Zeidler R, Csanady M, Gires O, Lang S, Schmitt B and Wollenberg B: Tumor cell-derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac-1. Faseb J 14: 661-668, 2000. (Pubitemid 30198565)
41. Kang H, Mansel RE and Jiang WG: Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells. Int J Oncol 26: 1429-1434, 2005.
42. Veltri RW, Rodman SM, Maxim PE, Baseler MW and Sprinkle PM: Immune complexes, serum proteins, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neck. Cancer 57: 2295-2308, 1986.
43. Heimdal JH, Aarstad HJ and Olofsson J: Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma. Laryngoscope 110: 402-407, 2000.
44. Cravens PD, Hayashida K, Davis LS, Nanki T and Lipsky PE: Human peripheral blood dendritic cells and monocyte subsets display similar chemokine receptor expression profiles with differential migratory responses. Scand J Immunol 65: 514-524, 2007. (Pubitemid 46808850)
45. Inngjerdingen M, Rolstad B and Ryan JC: Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12. J Immunol 171: 2889-2895, 2003. (Pubitemid 37093509)
46. Scandella E, Men Y, Legler DF, Gillessen S, Prikler L, Ludewig B and Groettrup M: CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 103: 1595-1601, 2004. (Pubitemid 38268947)
47. Legler DF, Krause P, Scandella E, Singer E and Groettrup M: Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J Immunol 176: 966-973, 2006. (Pubitemid 43099695)
48. Scandella E, Men Y, Gillessen S, Forster R and Groettrup M: Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100: 1354-1361, 2002. (Pubitemid 34864292)
49. Benefield J, Petruzzelli GJ, Fowler S, Taitz A, Kalkanis J and Young MR: Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas. Invasion Metastasis 16: 291-301, 1996. (Pubitemid 27482959)
50. Hwang SL, Chung NP, Chan JK and Lin CL: Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines. Cell Res 15: 167-175, 2005.
51. Dumitriu IE, Bianchi ME, Bacci M, Manfredi AA and Rovere-Querini P: The secretion of HMGB1 is required for the migration of maturing dendritic cells. J Leukoc Biol 81: 84-91, 2007. (Pubitemid 46021256)
52. Cella M, Facchetti F, Lanzavecchia A, and Colonna M: Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 1: 305-310, 2000.
53. Hansson M, Lundgren A, Elgbratt K, Quiding-Jarbrink M, Svennerholm AM and Johansson EL: Dendritic cells express CCR7 and migrate in response to CCL19 (MIP-3beta) after exposure to Helicobacter pylori. Microbes Infect 8: 841-850, 2006.
54. Worbs T and Forster R: A key role for CCR7 in establishing central and peripheral tolerance. Trends Immunol 28: 274-280, 2007. (Pubitemid 46810350)
55. Koizumi K, Kozawa Y, Ohashi Y, Nakamura ES, Aozuka Y, Sakurai H, Ichiki K, Doki Y, Misaki T, and Saiki I: CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro. Oncol Rep 17: 1511-1516, 2007.
56. Treilleux I, Blay JY, Bendriss-Vermare N, Ray-Coquard I, Bachelot T, Guastalla JP, Bremond A, Goddard S, Pin JJ, Barthelemy-Dubois C and Lebecque S: Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res 10: 7466-7474, 2004. (Pubitemid 39561754)